Citations

Clear

4207 citation(s) found for "Chen, Yu".

Tachycardia and the AV Nodal Region
Chen, Frank C., Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | February 16, 2010 | Volume: 3 | Issue: 1 | Pages: 2-6

10.1161/circep.110.937144 | PMID 20160175 Get It

Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium
Phelan, Catherine M., Tsai, Ya-Yu, Goode, Ellen L. , Vierkant, Robert A. , Beesley, Jonathan, Chen, Xiao Qing, Webb, Penelope M. , Moysich, Kirsten B., Edwards, Robert P., Chang‐Claude, Jenny , García‐Closas, Montserrat , Wang‐Gohrke, Shan , Hein, Rebecca, Lissowska, Jolanta , Carney, Michael E., Lurie, Galina, Ness, Roberta B., Pearce, Celeste Leigh, Wu, Anna H. , Berg, David J. Van Den, Terry, Kathryn L. , Whiteman, David C. , Whittemore, Alice S. , DiCioccio, Richard A., McGuire, Valerie , Rossing, Mary Anne, Høgdall, Claus , Høgdall, Estrid , Kjær, Susanne K. , Blaakær, Jan , Quaye, Lydia, Ramus, Susan J. , Jacobs, Ian , Song, Honglin , Iversen, Edwin S., Marks, Jeffrey R. , Pike, Malcolm C. , Gayther, Simon A. , Cunningham, Julie M. , Goodman, Marc T. , Schildkraut, Joellen M. , Chenevix‐Trench, Georgia , Sellers, Thomas A. , Group, Australian Ovarian Cancer Study, Fridley, Brooke L. , Chen, Xiao Qing, Chanock, Stephen Jacob , Cramer, Daniel W. , Yang, Hannah , Green, Adèle C. , Wilkens, Lynne R. , Stram, Daniel O. , Doherty, Jennifer A. , Anton‐Culver, Hoda , Ziogas, Argyrios , Pharoah, Paul D.P. , Berchuck, Andrew , Group, Australian Ovarian Cancer Study, Kjaer, Susanne K , Ramus, Susan J , Webb, Penelope M , Vierkant, Robert A , Moysich, Kirsten , Lissowska, Jolanta , García-Closas, Montserrat , Chenevix-Trench, Georgia , Høgdall, Estrid , Høgdall, Claus K , Whiteman, David C , Goodman, Marc T

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | February 8, 2010 | Volume: 19 | Issue: 2 | Pages: 600-604

10.1158/1055-9965.epi-09-0861 | PMID 20142253 Get It

Abstract Aberrant glycosylation is a well-described hallmark of cancer. In a previous ovarian cancer case control study that examined polymorphisms in 26 glycosylation-associated genes, we found strong statistical evidence (P = 0.00017) that women who inherited two copies of a single-nucleotide polymorphism in the UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase, GALNT1, had decreased ovarian cancer risk. The current study attempted to replicate this observation. The GALNT1 single-nucleotide polymorphism rs17647532 was genotyped in 6,965 cases and 8,377 controls from 14 studies forming the Ovarian Cancer Association Consortium. The fixed effects estimate per rs17647532 allele was null (odds ratio, 0.99; 95% confidence interval, 0.92-1.07). When a recessive model was fit, the results were unchanged. Test for hetero geneity of the odds ratios revealed consistency across the 14 replication sites but significant differences compared with the original study population (P = 0.03). This study underscores the need for replication of putative findings in genetic association studies. Cancer Epidemiol Biomarkers Prev; 19(2); 600–4
Systemic Fibrinolysis Caused by Tissue Plasminogen Activator–Producing Metastatic Breast Cancer
Naina, Harris, Patnaik, Mrinal M. , Ali, Uzma A., Chen, Dong , Ashrani, Aneel A. , Chen, Dong

Mayo Clinic

Journal of Clinical Oncology | January 12, 2010 | Volume: 28 | Issue: 11 | Pages: e167-e168

10.1200/jco.2009.25.2502 | PMID 20065179 Get It

Synthesis and Biological Evaluation of Triazol-4-ylphenyl-Bearing Histone Deacetylase Inhibitors as Anticancer Agents
He, Rong , Chen, Yihua , Ougolkov, Andrei V., Zhang, Jin‐San , Savoy, Doris N., Billadeau, Daniel D. , Kozikowski, Alan P. , Ugolkov, Andrey , Chen, Yufeng

Mayo Clinic

Journal of Medicinal Chemistry | January 7, 2010 | Volume: 53 | Issue: 3 | Pages: 1347-1356

10.1021/jm901667k | PMID 20055418 Get It

ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study
Rossing, Mary Anne, Cushing‐Haugen, Kara L. , Chen, Chu , Berg, David J. Van Den, Wu, Anna H. , Pike, Malcolm C. , Ness, Roberta B., Moysich, Kirsten B., Chenevix‐Trench, Georgia , Beesley, Jonathan, Webb, Penelope M. , Chang‐Claude, Jenny, Wang‐Gohrke, Shan , Goodman, Marc T. , Lurie, Galina, Thompson, Pamela J., Carney, Michael E., Høgdall, Estrid , Kjær, Susanne K. , Høgdall, Claus , Goode, Ellen L. , Cunningham, Julie M. , Vierkant, Robert A. , Moorman, Patricia G. , Schildkraut, Joellen M. , Palmieri, Rachel T., Terry, Kathryn L. , García‐Closas, Montserrat , Lissowska, Jolanta , Song, Honglin , Shah, Mitul , Perkins, Barbara, McGuire, Valerie , Whittemore, Alice S. , Cioccio, Richard A. Di, Menon, Usha , Gayther, Simon A. , Ramus, Susan J. , Group, The Australian Ovarian Cancer Study Management, Cancer), The Australian Cancer Study (Ovarian, Pearce, Celeste Leigh, Weber, Rachel Palmieri , Doherty, Jennifer A. , Fridley, Brooke L. , Berchuck, Andrew , Cramer, Daniel W. , Yang, Hannah , Chanock, Stephen Jacob , Pharoah, Paul D.P. , Gentry‐Maharaj, Aleksandra , Ziogas, Argyrios , Brewster, Wendy R. , Anton‐Culver, Hoda , Group, The Australian Ovarian Cancer Study Management, Cancer), The Australian Cancer Study (Ovarian, Pearce, Celeste Leigh, Kjaer, Susanne K , Ramus, Susan J , Webb, Penelope M , Vierkant, Robert A , Menon, Usha , Moysich, Kirsten , Lissowska, Jolanta , García-Closas, Montserrat , Chenevix-Trench, Georgia , Høgdall, Estrid , Høgdall, Claus K , Goodman, Marc T

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | January 7, 2010 | Volume: 19 | Issue: 1 | Pages: 245-250

10.1158/1055-9965.epi-09-0729 | PMID 20056644 Get It

Abstract We genotyped 13 single nucleotide polymorphisms (SNPs) in the estrogen receptor alpha gene (ESR1) region in three population-based case-control studies of epithelial ovarian cancer conducted in the United States, comprising a total of 1,128 and 1,866 non-Hispanic white invasive cases and controls, respectively. A SNP 19 kb downstream of ESR1 (rs2295190, G-to-T change) was associated with invasive ovarian cancer risk, with a per-T-allele odds ratio (OR) of 1.24 [95% confidence interval (CI), 1.06-1.44, P = 0.006]. rs2295190 is a nonsynonymous coding SNP in a neighboring gene called spectrin repeat containing, nuclear envelope 1 (SYNE1), which is involved in nuclear organization and structural integrity, function of the Golgi apparatus, and cytokinesis. An isoform encoded by SYNE1 has been reported to be downregulated in ovarian and other cancers. rs2295190 was genotyped in an additional 12 studies through the Ovarian Cancer Association Consortium, with 5,279 invasive epithelial cases and 7,450 controls. The per-T-allele OR for this 12-study set was 1.09 (95% CI, 1.02-1.17; P = 0.017). Results for the serous subtype in the 15 combined studies were similar to those overall (n = 3,545; OR, 1.09; 95% CI, 1.01-1.18; P = 0.025), and our findings were strongest for the mucinous subtype (n = 447; OR, 1.32; 95% CI, 1.11-1.58; P = 0.002). No association was observed for the endometrioid subtype. In an additional analysis of 1,459 borderline ovarian cancer cases and 7,370 controls, rs2295190 was not associated with risk. These data provide suggestive evidence that the rs2295190 T allele, or another allele in linkage disequilibrium with it, may be associated with increased risk of invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev; 19(1); 244–50
Quantification of Serum 1–84 Parathyroid Hormone in Patients with Hyperparathyroidism by Immunocapture In Situ Digestion Liquid Chromatography–Tandem Mass Spectrometry
Barnidge, David R. , Chen, Li-Sheng, Twentyman, Jolaine M, Cradic, Kendall W, Grebe, Stefan K., Kumar, Vivek , Singh, Ravinder

Mayo Clinic

Clinical Chemistry | December 11, 2009 | Volume: 56 | Issue: 2 | Pages: 306-313

10.1373/clinchem.2009.134643 | PMID 20007860 Get It

Abstract Background: Immunoassays specific for 1–84 parathyroid hormone (PTH) reportedly reflect the bioactivity of PTH; however, PTH immunoassays can be susceptible to interference by cross-reacting PTH fragments. In addition, these assays currently lack standardization. A methodology using immunocapture purification with liquid chromatography–tandem mass spectrometry (LC-MS/MS) detection, along with a stable isotope–labeled internal standard, may help address these issues. Methods: We isolated 1–84 PTH from 1 mL serum by immunocapture on a 6.5-mm polystyrene bead. The immobilized PTH was digested in situ and analyzed by LC-MS/MS. For quantification, we used the selected reaction monitoring response from the N-terminal tryptic peptide 1–13 PTH (1SVSEIQLMHNLGK13). Results: The linear range of the assay was 39.1–4560 ng/L, and the limit of detection and limit of quantification were 14.5 ng/L and 39.1 ng/L, respectively. The intraassay CVs ranged from 6% to 11%, and the interassay CVs ranged from 7% to 17%. Interference by PTH fragments 1–44 PTH, 7–84 PTH, 43–68 PTH, 52–84 PTH, 64–84 PTH, and PTH-related protein (PTHrP) was ≤1% to ≤0.001%. Method comparison of LC-MS/MS vs the Roche Cobas® immunoassay yielded Deming fit of LC-MS/MS = 1.01x immunoassay – 13.21. The mean bias by Bland–Altman plot was −9.4%. Conclusions: In patients with hyperparathyroidism, the immunocapture in situ digestion LC-MS/MS method can provide accurate and precise PTH results compared with immunoassay.
Src-Mediated Phosphorylation of Dynamin and Cortactin Regulates the “Constitutive” Endocytosis of Transferrin
Cao, Hong , Chen, Jing , Krueger, Eugene W. , McNiven, Mark A.

Mayo Clinic

Molecular and Cellular Biology | December 8, 2009 | Volume: 30 | Issue: 3 | Pages: 781-792

10.1128/mcb.00330-09 | PMID 19995918 Get It

Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
Hsieh, Ting–Hui, Liu, Chun‐Jen , Lai, Ming–Yang, Chen, Pei‐Jer , Hsieh, Hsin-Ling , Chen, Ding‐Shinn , Kao, Jia‐Horng , Tseng, Tai‐Chung

Mayo Clinic

Antiviral Therapy | November 27, 2009 | Volume: 14 | Issue: 8 | Pages: 1157-1163

10.3851/imp1454 | PMID 20032545 Get It

Background Hepatitis B virus (HBV) genotype B and C seem not to affect the therapeutic response to lamivudine (3TC). Whether a given genotype has an earlier emergence of 3TC resistance remains unclear. We thus conducted this study to elucidate the association of HBV genotype with the emergence of 3TC-resistant strains in Taiwanese patients. Methods Forty chronic hepatitis B patients who developed resistance after 3TC therapy were retrospectively enrolled. HBV genotype, serum alanine aminotransferase (ALT) and HBV DNA levels were determined at baseline. The presence of 3TC-resistant mutations was confirmed by direct sequencing whenever biochemical breakthrough developed. Results The distribution of HBV genotype B and C in 40 patients receiving 3TC therapy were 60% and 40%, respectively. The mean interval to detect 3TC- resistant strain was 19.6 ±1.7 months. By using multivariate analysis, HBV genotype B and higher pre-treatment HBV DNA level were independently associated with earlier detection of 3TC-resistant strains. In addition, genotype B was significantly associated with development of 3TC resistance within the first 12 months of 3TC therapy compared with genotype C (odds ratio 8.27; P=0.004). Conclusions Compared with HBV genotype C, genotype B appears to have an earlier biochemical resistance to 3TC than genotype C. Therefore, more frequent monitoring of viral load or genotypical resistance might be needed for patients with HBV genotype B infection receiving 3TC therapy, especially during the first year.
Molecular mechanisms of Cryptosporidium -induced host actin cytoskeleton dynamics.
O’Hara, Steven P. , Chen, X. M., LaRusso, N. F., Chen, X. M.

Mayo Clinic

Giardia and Cryptosporidium: from molecules to disease | November 16, 2009 | Volume: No volume available | Issue: No issue available | Pages: 418-427

10.1079/9781845933913.0418 Get It

Tissue heating in vibro-acoustography.
Aquino, Wilkins , Urban, Matthew W. , Greenleaf, James F. , Chen, Shigao , Alizad, Azra , Fatemi, Mostafa , Urban, Matthew W

Mayo Clinic

The Journal of the Acoustical Society of America | October 7, 2009 | Volume: 126 | Issue: 4_Supplement | Pages: 2176-2176

10.1121/1.3248501 Get It

Vibro-acoustography (VA) is an imaging method based on ultrasound radiation force. In this method, a two dimensional image is formed by scanning two co-focused ultrasound beams with slightly different frequencies over the object (biological tissue) in a C-scan format and recording resulting sound that is emitted from the focal region at the difference frequency. As in other ultrasound-based imaging modalities, it is important to study the thermal safety of the technique. This paper addresses tissue heating due to a VA scan using a concentric confocal transducer. The three dimensional ultrasound intensity field calculated by Field II is used with the bio-heat equation to estimate tissue heating. Results calculated with thermal conduction and with blood perfusion, with conduction and without perfusion, and without conduction and without perfusion are compared. Maximum temperature rise occurs in the transducer near field during VA scans. Heating during one VA scan is below 0.05 °C for soft tissue with attenuation coefficient of 0.3, 0.5, or 0.7 dB/cm MHz. It is concluded that temperature rise in tissue is not significant. [Work supported by NIH Grants CA 91956, CA 127235, and CA121579. Some of the techniques are patented by Mayo Clinic and the some of the authors (M.F. and J.F.G.).]